10.17.25 -- The FDA 483 Heard Round The World

Explore how Simulated Moving Bed (SMB) technology can enhance API production while overcoming common misconceptions about chromatographic purification.

To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.

Artificial intelligence promises productivity boosts and accelerated innovation. But using them invites risk, including accidentally exposing intellectual property.

JHS boosted vaccine vial inspection speed 4x with automated visual inspection, improving accuracy, efficiency, and capacity to 20 million vials annually using the Seidenader CS-40.

Discover a reliable solution for labeling small batches of medical products, including vials, syringes, and cartridges, that fully automatic machines struggle to handle.

In this presentation, we delve into how expedited review pathways can be strategically used to accelerate development while mitigating CMC risks.

Leverage expert small molecule solutions from preclinical development to commercial manufacturing, with strengths in large-scale oral solids, advanced formulations, and more.

Consider using our end-to-end CDMO services for oral solid dose drugs to enable efficient development, manufacturing, and packaging with advanced technologies and global scale.

We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.